<?xml version="1.0" encoding="UTF-8"?>
<p id="p0740">Immunosuppressed patients are at greater risk of severe pneumonia and disseminated disease. The commonest sites of dissemination are skin, bone, and meninges. Patients diagnosed with coccidioidomycosis while being treated with biological therapies should be started on oral antifungal treatment unless there are features of severe illness or dissemination in which case intravenous therapy may be indicated. Serological screening prior to commencing treatment with biologics is recommended in endemic areas [
 <xref rid="bib92" ref-type="bibr">92</xref>]. Coccidioidomycosis should be suspected in travelers returning from endemic areas with compatible symptoms.
</p>
